Data-driven parametric reduced-order models (ROMs) in state-space form are valuable tools for rapid aeroelastic (AE) analysis and aerostructure control synthesis. However, the issue of state inconsistence (significant variations in model parameters over tradespaces) makes ROMs noninterpolatable, and therefore unable to accommodate use over broad flight parameter space. This paper presents a holistic framework that combines a system identification technique with state-consistence enforcement (SCE) and a genetic algorithm (GA) for the automated development of interpolatable AE ROMs across broad flight regimes. The SCE technique introduces a regularization term to the AutoRegressive model with eXogenous inputs (ARX) to specifically penalize model parameter variation between flight conditions. The GA autonomously guides the ROM development process toward optimal SCE-ARX hyperparameter selection that balances between model parameter variations and ROM accuracy. The GA-guided SCE-ARX approach is applied to build a parametric AE-ROM database at selected flight conditions, which, because of its state consistence, can be interpolated to create ROMs at any interstitial conditions, where training data or ROMs are not initially available, hence rapidly establishing the full coverage of the entire parameter space. The ROMs generated by the proposed method are compared with those by ARX, SCE, and GA-guided ARX in prediction accuracy. The individual and combined effects of SCE and GA on model parameter variation and ROM interpolatability are thoroughly investigated. The present method demonstrates the most accurate and robust performance for parametric ROM construction across the broad flight envelope.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.